StacksVerified U.S. regulatory reference

21 CFR §316.40

Verified against eCFR.gov as of June 20, 2026View official text on eCFR.gov
Prospective investigators seeking to obtain treatment use of designated orphan drugs may do so as provided in subpart I of this chapter.